PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
-8.5%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.71B
AUM Growth
+$3.71B
Cap. Flow
+$5.42M
Cap. Flow %
0.15%
Top 10 Hldgs %
52.12%
Holding
129
New
22
Increased
22
Reduced
15
Closed
19

Top Buys

1
SWTX
SpringWorks Therapeutics
SWTX
$69.8M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$32.3M
3
SLDB icon
Solid Biosciences
SLDB
$29.2M
4
FOLD icon
Amicus Therapeutics
FOLD
$24.9M
5
YMAB icon
Y-mAbs Therapeutics
YMAB
$22.3M

Top Sells

1
ASND icon
Ascendis Pharma
ASND
$54.5M
2
ARRY
Array Biopharma Inc
ARRY
$48.1M
3
BPMC
Blueprint Medicines
BPMC
$24.2M
4
QURE icon
uniQure
QURE
$22M
5
TDOC icon
Teladoc Health
TDOC
$20.4M

Sector Composition

1 Healthcare 93.95%
2 Financials 0.46%
3 Consumer Discretionary 0.18%
4 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRNX icon
26
Crinetics Pharmaceuticals
CRNX
$3.26B
$38.9M 1.05%
2,587,953
– –
TVTX icon
27
Travere Therapeutics
TVTX
$1.75B
$37.9M 1.02%
3,270,571
-502,011
-13% -$5.82M
MNTA
28
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$37.6M 1.01%
2,905,000
– –
ALBO
29
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$34.1M 0.92%
1,704,330
– –
FOMX
30
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$34.1M 0.92%
11,203,881
+6,542,057
+140% +$19.9M
ONCE
31
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$33.9M 0.91%
350,000
– –
KDMN
32
DELISTED
Kadmon Holdings, Inc.
KDMN
$33.2M 0.89%
13,165,746
– –
DBVT
33
DBV Technologies
DBVT
$249M
$31M 0.84%
3,609,084
– –
EIDX
34
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$24.7M 0.67%
686,992
– –
CTMX icon
35
CytomX Therapeutics
CTMX
$350M
$24M 0.65%
3,253,923
+100,000
+3% +$738K
ESTA icon
36
Establishment Labs
ESTA
$1.11B
$23.8M 0.64%
1,260,528
– –
NVTA
37
DELISTED
Invitae Corporation
NVTA
$23.1M 0.62%
1,198,182
-145,309
-11% -$2.8M
RCKT icon
38
Rocket Pharmaceuticals
RCKT
$358M
$23M 0.62%
1,977,412
– –
TPTX
39
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$22.5M 0.6%
597,190
+172,222
+41% +$6.48M
YMAB icon
40
Y-mAbs Therapeutics
YMAB
$390M
$22.3M 0.6%
+854,940
New +$22.3M
RGNX icon
41
Regenxbio
RGNX
$498M
$21.6M 0.58%
608,000
-362,997
-37% -$12.9M
BIO icon
42
Bio-Rad Laboratories Class A
BIO
$7.8B
$21.6M 0.58%
+65,000
New +$21.6M
UROV
43
DELISTED
Urovant Sciences Ltd.
UROV
$21.3M 0.57%
2,246,547
+371,121
+20% +$3.51M
EHTH icon
44
eHealth
EHTH
$126M
$17M 0.46%
255,089
-130,893
-34% -$8.74M
VAPO
45
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$16.7M 0.45%
1,764,470
+360,000
+26% +$3.41M
ALDX icon
46
Aldeyra Therapeutics
ALDX
$350M
$16.3M 0.44%
3,085,458
– –
MMSI icon
47
Merit Medical Systems
MMSI
$5.34B
$16.1M 0.43%
528,788
-288,421
-35% -$8.79M
STOK icon
48
Stoke Therapeutics
STOK
$1.08B
$14.4M 0.39%
671,978
– –
MTEM
49
DELISTED
Molecular Templates, Inc.
MTEM
$13M 0.35%
1,974,133
– –
CNCE
50
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$12.9M 0.35%
2,194,641
-10,000
-0.5% -$58.8K
1
2
3 4 5